KEY FINDINGS
The Asia Pacific market region, with regard to veterinary vaccines, is predicted to register a CAGR of 6.25% over the estimated period of 2020-2028. The important factors boosting the market growth are a wide range of product launches and investments in vaccine manufacturing facilities, especially in China, India, and Thailand.
MARKET INSIGHTS
The Asia Pacific veterinary vaccines market is further analyzed by segregating the region into countries such as South Korea, China, Australia & New Zealand, Indonesia, India, Japan, Vietnam, Thailand, and the rest of Asia Pacific that includes Malaysia, Philippines, Singapore, and Cambodia. In South Korea, the increasing prevalence of animal diseases, coupled with various initiatives related to vaccination for animals, is propelling the growth of the market in this region. In countries like Thailand, drug law regulates both human and veterinary medicinal products. All medical products require licensing for manufacturing, selling, importing, and registration. The swine industry is huge in Thailand and is plagued by viral epidemics. The country imports all of its animal vaccines at present, but they are often ineffective, driving the demand for the market. In Indonesia, traditionally, poultry plays a major role in the lives of its people. Poultry contributes 60% of the national meat supply. In keeping with the increased demand for poultry meat, Indonesia continued to contribute to the improved health of poultry. Vietnam has managed to eradicate most of the diseases like bird flu, blue ear, or foot and mouth disease among cattle and poultry, according to the Department of Animal Health. In the rest of the Asia Pacific region, growth in the vaccines market can be attributed to the growing livestock population, increasing awareness about animal health and zoonotic diseases, and the frequent outbreaks of animal diseases in these regions.
COMPETITIVE INSIGHTS
Elanco, Virbac SA, Hester Biosciences Ltd., Zoetis Inc., Merck & Co., Inc., etc. are some of the leading companies operating in the market.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Asia Pacific Veterinary Vaccines Market Forecast 2020-2028
Table of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summaries
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Progression In The Vaccine Products
3.2.2. Increasing Government Initiatives
3.2.3. Increasing Incidence Of Zoonotic Diseases
3.2.4. Surge In The Companion Animal Ownership
3.2.5. Growing Prevalence Of Livestock Diseases
3.3. Key Restraints
3.3.1. High Cost Of Vaccinations
3.3.2. Side Effects Associated With Veterinary Vaccines On Human And Animal Health
3.3.3. Lack Of Skilled Farmworkers And Veterinarians
4. Key Analytics
4.1. Porter's Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Value Chain Analysis
4.3. Regulatory Framework
4.4. Opportunity Matrix
4.5. Vendor Landscape
5. Market By Vaccine Type
5.1. Livestock Vaccine
5.1.1. Porcine Vaccine
5.1.2. Bovine Vaccine
5.1.3. Poultry Vaccine
5.1.4. Aquaculture Vaccine
5.1.5. Other Livestock Vaccine
5.2. Companion Vaccine
5.2.1. Canine Vaccine
5.2.2. Feline Vaccine
5.2.3. Equine Vaccine
6. Market By Technology
6.1. Live Attenuated Vaccine
6.2. Inactivated Vaccine
6.3. Recombinant Vaccine
6.4. Toxoid Vaccine
6.5. Other Technology
7. Market By Disease Type
7.1. Canine Disease
7.2. Porcine Disease
7.3. Bovine Disease
7.4. Poultry Disease
7.5. Aquaculture Disease
7.6. Other Disease Type
8. Geographical Analysis
8.1. Asia Pacific
8.1.1. China
8.1.2. Japan
8.1.3. India
8.1.4. Australia & New Zealand
8.1.5. South Korea
8.1.6. Thailand
8.1.7. Indonesia
8.1.8. Vietnam
8.1.9. Rest Of Asia Pacific
9. Company Profiles
9.1. Anicon Labor Gmbh
9.2. Boehringer Ingelheim Animal Health Gmbh
9.3. Ceva Sante Animale
9.4. Elanco (Eli Lilly And Company)
9.5. Hester Biosciences Limited
9.6. Hipra
9.7. Hygieia Biological Laboratories
9.8. Merck & Co.
9.9. Phibro Animal Health Corp.
9.10. Romvac Company S.A.
9.11. Vaxxinova Gmbh-Germany
9.12. Virbac Sa
9.13. Zoetis Animal Healthcare
List of Tables
Table 1: Market Snapshot - Veterinary Vaccine
Table 2: Asia Pacific Veterinary Vaccines, By Vaccine Type, Historical Years, 2016-2019 (In $ Million)
Table 3: Asia Pacific Veterinary Vaccines, By Vaccine Type, Forecast Years, 2020-2028 (In $ Million)
Table 4: Asia Pacific Livestock Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 5: Asia Pacific Livestock Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 6: Asia Pacific Livestock Vaccine Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 7: Asia Pacific Livestock Vaccine Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 8: Asia Pacific Porcine Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 9: Commercially Available Porcine Vaccines
Table 10: Asia Pacific Porcine Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 11: Asia Pacific Bovine Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 12: Commercially Available Bovine Vaccines
Table 13: Asia Pacific Bovine Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 14: Asia Pacific Poultry Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 15: Commercially Available Poultry Vaccines
Table 16: Asia Pacific Poultry Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 17: Asia Pacific Aquaculture Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 18: Commercially Available Aquaculture Vaccines
Table 19: Asia Pacific Aquaculture Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 20: Asia Pacific Other Livestock Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 21: Asia Pacific Other Livestock Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 22: Asia Pacific Companion Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 23: Asia Pacific Companion Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 24: Asia Pacific Companion Vaccine Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 25: Asia Pacific Companion Vaccine Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 26: Asia Pacific Canine Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 27: Commercially Available Canine Vaccines
Table 28: Asia Pacific Canine Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 29: Asia Pacific Feline Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 30: Commercially Available Feline Vaccines
Table 31: Asia Pacific Feline Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 32: Asia Pacific Equine Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 33: Commercially Available Equine Vaccines
Table 34: Asia Pacific Equine Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 35: Asia Pacific Veterinary Vaccines, By Technology, Historical Years, 2016-2019 (In $ Million)
Table 36: Asia Pacific Veterinary Vaccines, By Technology, Forecast Years, 2020-2028 (In $ Million)
Table 37: Asia Pacific Live Attenuated Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 38: Asia Pacific Live Attenuated Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 39: Asia Pacific Inactivated Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 40: Asia Pacific Inactivated Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 41: Asia Pacific Recombinant Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 42: Asia Pacific Recombinant Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 43: Asia Pacific Toxoid Vaccine Market, Historical Years, 2016-2019 (In $ Million)
Table 44: Asia Pacific Toxoid Vaccine Market, Forecast Years, 2020-2028 (In $ Million)
Table 45: Asia Pacific Other Technology Market, Historical Years, 2016-2019 (In $ Million)
Table 46: Asia Pacific Other Technology Market, Forecast Years, 2020-2028 (In $ Million)
Table 47: Asia Pacific Veterinary Vaccines, By Disease Type, Historical Years, 2016-2019 (In $ Million)
Table 48: Asia Pacific Veterinary Vaccines, By Disease Type, Forecast Years, 2020-2028 (In $ Million)
Table 49: Asia Pacific Canine Disease Market, Historical Years, 2016-2019 (In $ Million)
Table 50: Asia Pacific Canine Disease Market, Forecast Years, 2020-2028 (In $ Million)
Table 51: Asia Pacific Porcine Disease Market, Historical Years, 2016-2019 (In $ Million)
Table 52: Asia Pacific Porcine Disease Market, Forecast Years, 2020-2028 (In $ Million)
Table 53: Asia Pacific Bovine Disease Market, Historical Years, 2016-2019 (In $ Million)
Table 54: Asia Pacific Bovine Disease Market, Forecast Years, 2020-2028 (In $ Million)
Table 55: Asia Pacific Poultry Disease Market, Historical Years, 2016-2019 (In $ Million)
Table 56: Asia Pacific Poultry Disease Market, Forecast Years, 2020-2028 (In $ Million)
Table 57: Asia Pacific Aquaculture Disease Market, Historical Years, 2016-2019 (In $ Million)
Table 58: Asia Pacific Aquaculture Disease Market, Forecast Years, 2020-2028 (In $ Million)
Table 59: Asia Pacific Other Disease Type Market, Historical Years, 2016-2019 (In $ Million)
Table 60: Asia Pacific Other Disease Type Market, Forecast Years, 2020-2028 (In $ Million)
Table 61: Asia Pacific Veterinary Vaccine Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 62: Asia Pacific Veterinary Vaccine Market, By Country, Forecast Years, 2020-2028 (In $ Million)
List of Figures
Figure 1: Porter's Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Asia Pacific Veterinary Vaccines, By Vaccine Type, In 2019
Figure 5: Asia Pacific Veterinary Vaccines Market, By Livestock Vaccine, 2020-2028 (In $ Million)
Figure 6: Asia Pacific Livestock Vaccine Market, By Porcine Vaccine, 2020-2028 (In $ Million)
Figure 7: Asia Pacific Livestock Vaccine Market, By Bovine Vaccine, 2020-2028 (In $ Million)
Figure 8: Asia Pacific Livestock Vaccine Market, By Poultry Vaccine, 2020-2028 (In $ Million)
Figure 9: Asia Pacific Livestock Vaccine Market, By Aquaculture Vaccine, 2020-2028 (In $ Million)
Figure 10: Asia Pacific Livestock Vaccine Market, By Other Livestock Vaccine, 2020-2028 (In $ Million)
Figure 11: Asia Pacific Veterinary Vaccines Market, By Companion Vaccine, 2020-2028 (In $ Million)
Figure 12: Asia Pacific Companion Vaccine Market, By Canine Vaccine, 2020-2028 (In $ Million)
Figure 13: Asia Pacific Companion Vaccine Market, By Feline Vaccine, 2020-2028 (In $ Million)
Figure 14: Asia Pacific Companion Vaccine Market, By Equine Vaccine, 2020-2028 (In $ Million)
Figure 15: Asia Pacific Veterinary Vaccines, By Technology, In 2019
Figure 16: Asia Pacific Veterinary Vaccines Market, By Live Attenuated Vaccine, 2020-2028 (In $ Million)
Figure 17: Asia Pacific Veterinary Vaccines Market, By Inactivated Vaccine, 2020-2028 (In $ Million)
Figure 18: Asia Pacific Veterinary Vaccines Market, By Recombinant Vaccine, 2020-2028 (In $ Million)
Figure 19: Asia Pacific Veterinary Vaccines Market, By Toxoid Vaccine, 2020-2028 (In $ Million)
Figure 20: Asia Pacific Veterinary Vaccines Market, By Other Technology, 2020-2028 (In $ Million)
Figure 21: Asia Pacific Veterinary Vaccines, By Disease Type, In 2019
Figure 22: Asia Pacific Veterinary Vaccines Market, By Canine Disease, 2020-2028 (In $ Million)
Figure 23: Asia Pacific Veterinary Vaccines Market, By Porcine Disease, 2020-2028 (In $ Million)
Figure 24: Asia Pacific Veterinary Vaccines Market, By Bovine Disease, 2020-2028 (In $ Million)
Figure 25: Asia Pacific Veterinary Vaccines Market, By Poultry Disease, 2020-2028 (In $ Million)
Figure 26: Asia Pacific Veterinary Vaccines Market, By Aquaculture Disease, 2020-2028 (In $ Million)
Figure 27: Asia Pacific Veterinary Vaccines Market, By Other Disease Type, 2020-2028 (In $ Million)
Figure 28: Asia Pacific Veterinary Vaccine Market, Country Outlook, 2019 & 2028 (In %)
Figure 29: China Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 30: Japan Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 31: India Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 32: Australia & New Zealand Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 33: South Korea Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 34: Thailand Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 35: Indonesia Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 36: Vietnam Veterinary Vaccine Market, 2020-2028 (In $ Million)
Figure 37: Rest Of Asia Pacific Veterinary Vaccine Market, 2020-2028 (In $ Million)
Global Classical Swine Fever Vaccines Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 100
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
Global Tylosin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
Global Animal Parasiticides Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 106
According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
Global Newcastle Disease Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
Global Classical Swine Fever Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 126
According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
Global Veterinary Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
Global Veterinary Products for Companion Animals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 115
According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
